The new method successfully performs sterility assessments within 24 hours
News
bit.bio and KCL to collaborate for neurodevelopmental disorders
The partners will utilise bit.bio’s ioCells to develop multi-cell models of the human brain
Milner Therapeutics to establish new genomics laboratory for drug discovery
The new state-of-the-art facility is set to be operational in early 2024
AI-powered ‘MesoGraph’ tool could help clinicians diagnose cancer
Around 3,000 new cases of mesothelioma are diagnosed in the US every year
Clinical trial reveals positive results for treating children with rare gliomas
Tafinlar and Mekinist led to a 56% overall response rate in children with BM-HGG
New NHS software set to improve care for millions of patients
Around £330m will be invested in the software over the next seven years
MHRA launches online eligibility checker tool via the IRP
The IRP will bring life-saving medicines to UK patients from 1 January 2024
Study suggests cognitive decline could be linked to hippocampus shrinkage
The findings could benefit patients living with neurodegenerative conditions
NHS urges individuals to take up cervical screening invitations
Around 3,200 new cases of cervical cancer are diagnosed in the UK every year
Genentech and NVIDIA enter into strategic AI research collaboration
Both companies will use their platforms to accelerate drug discovery and development
Alladapt’s allergy treatment receives FDA fast track designation
ADP101 is an oral immunotherapy to treat multi-food and single-food allergies
PREDICTOM trial backed by €21m for early Alzheimer’s detection
The trial will use an AI screening platform to identify those most at risk of dementia
Thousands of men to participate in UK trial for prostate cancer
Prostate cancer is responsible for 12,000 deaths every year in the UK
Two charities co-fund £5.5m childhood cancer research programme
SMPaeds2 aims to advance precision medicines for children with relapsed cancer
Lab-grown blood vessels could potentially treat strokes and vascular dementia
Cerebral SVD contributes to 45% of dementia cases and 20% of ischaemic strokes
